免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

GlidePath 13F 長期血液透析針管

K 號:K211410 · 2021-06-04

決定日期2021-06-04
產品代碼MSD
諮詢委員會GU
決定Unknown

器材摘要

GlidePath 13F Long-Term Hemodialysis Catheter is the device name listed in this FDA 510(k) record. The listed applicant is Bard Peripheral Vascular, Inc.. It received FDA 510(k) clearance on 2021-06-04 under 510(k) number K211410. The device is classified under product code MSD. It was reviewed by the GU advisory panel. FDA Decision: Unknown.

常見問題

What is the GlidePath 13F Long-Term Hemodialysis Catheter?

GlidePath 13F Long-Term Hemodialysis Catheter is a medical device that received FDA 510(k) clearance on 2021-06-04. The listed applicant is Bard Peripheral Vascular, Inc.. The 510(k) number is K211410.

When did GlidePath 13F Long-Term Hemodialysis Catheter receive FDA 510(k) clearance?

GlidePath 13F Long-Term Hemodialysis Catheter received FDA 510(k) clearance on 2021-06-04, under 510(k) number K211410.

Who is the listed applicant for GlidePath 13F Long-Term Hemodialysis Catheter?

FDA 510(k) 記錄將 Bard Peripheral Vascular, Inc. 列為申請人。這並不單獨確立設備製造商。

What is the FDA product code for GlidePath 13F Long-Term Hemodialysis Catheter?

The FDA product code for GlidePath 13F Long-Term Hemodialysis Catheter is MSD.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Bard Peripheral Vascular, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 18 項裝置 →

相關器械(代碼:MSD)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑